Girish Aakalu - Dec 31, 2021 Form 5 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
CHIEF BUSINESS OFFICER
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Girish Aakalu
Stock symbol
GNCA
Transactions as of
Dec 31, 2021
Transactions value $
-$3,646
Form type
5
Date filed
3/16/2022, 05:25 PM
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$2.51K -925 -1.73% $2.71 52.4K Apr 2, 2021 Direct F1
transaction GNCA Common Stock Sale -$1.14K -511 -0.98% $2.23 51.9K Jun 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.